Clinical Trial Update: A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating epoetin alfa to facilitate self-donation of blood before orthopedic surgery in patients with low hematocrit, assessing sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Epogen (epoetin alfa)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Blood Transfusion | Phase 2, Phase 3 | Status: COMPLETED